WCLC 2025 - Posters & ePosters-P2.10.12 Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant NSCLC: Final Results From the DESTINY-Lung05 Study

P2.10.12 Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant NSCLC: Final Results From the DESTINY-Lung05 Study

Asset Subtitle

Buhai Wang

Meta Tag

Speaker Buhai Wang

Topic Metastatic Non-small Cell Lung Cancer – Cytotoxic Therapy